304 related articles for article (PubMed ID: 25213452)
1. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
3. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
[TBL] [Abstract][Full Text] [Related]
4.
Schott S; Yang R; Stöcker S; Canzian F; Giese N; Bugert P; Bergmann F; Strobel O; Hackert T; Sohn C; Burwinkel B
Oncotarget; 2017 Sep; 8(40):67614-67625. PubMed ID: 28978057
[TBL] [Abstract][Full Text] [Related]
5. [Detection of DNA methylation of
Yin Y; Li H; Yang C; Zhang M; Huang X; Li M; Yang R; Zhang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):123-129. PubMed ID: 35249879
[TBL] [Abstract][Full Text] [Related]
6. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.
Pfütze K; Benner A; Hoffmeister M; Jansen L; Yang R; Bläker H; Herpel E; Ulrich A; Ulrich CM; Chang-Claude J; Brenner H; Burwinkel B
Genomics; 2015 Dec; 106(6):348-54. PubMed ID: 26453961
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
8. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
9. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
10. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
11. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
12. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Breast Cancer and Blood-Based Methylation of
Yin Q; Yang X; Li L; Xu T; Zhou W; Gu W; Ma F; Yang R
Front Genet; 2020; 11():977. PubMed ID: 33005177
[TBL] [Abstract][Full Text] [Related]
14. A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression.
Zhang Y; Zhang J; Liu Z; Liu Y; Tuo S
Biochem Biophys Res Commun; 2015 Sep; 465(3):437-42. PubMed ID: 26282201
[TBL] [Abstract][Full Text] [Related]
15. The association between RAPSN methylation in peripheral blood and breast cancer in the Chinese population.
Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Gu W; Ma F; Yang R
J Hum Genet; 2021 Nov; 66(11):1069-1078. PubMed ID: 33958711
[TBL] [Abstract][Full Text] [Related]
16. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
17. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
[TBL] [Abstract][Full Text] [Related]
18. S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
Maierthaler M; Kriegsmann M; Peng C; Jauch S; Szabo A; Wallwiener M; Rom J; Sohn C; Schneeweiss A; Sinn HP; Yang R; Burwinkel B
Exp Mol Pathol; 2015 Aug; 99(1):180-7. PubMed ID: 26112095
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
